Benzodiazepine Market Forecast by 2022; AstraZeneca, GlaxoSmithKline, Sanofi and More

The Benzodiazepine Market to grow at a CAGR of 1.5% to 2.3% by 2022. The International Narcotics Control Board (INCB) reported that Italy (32 %), India (19 %), China (11 %) and Germany (10 %) were the leading manufacturers between 1997 and 2006.

Benzodiazepines (BZD) are a class of psychoactive drugs with sedative, hypnotic (sleep-inducing), anti-anxiety, anticonvulsant, and muscle relaxant properties. Benzodiazepines (BZD) are useful in treating anxiety, insomnia, agitation, seizures, muscle spasms and alcohol withdrawal.

The sale of Benzodiazepine has been declining due to their addictive side effects and the rise of alternate drugs such as selective serotonin reuptake inhibitors. However the last few years have witnessed a moderate rise in the sale of Benzodiazepines. The lack of efficacy and slow onset of action of selective serotonin reuptake inhibitors along with the fear of falling back on first generation anti-psychotic (barbiturate class) drugs have negated any market moves against Benzodiazepines. Development of short acting Benzodiazepines is an additional advantage in favour of barbiturates.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/2281 .

Some more restraints hampering the market growth are highly competitive and segmented market and a shift towards non-pharmacological therapies.

Key Player - Global Benzodiazepine market:

The Global Benzodiazepine market has been evaluated as a slowly growing market and it is expected that the market will reflect sluggish growth figures in future. The global Benzodiazepine market is expected to grow with CAGR of ~ 1.5% to 2.3 % during the forecast period.

The major participants of this market are: AstraZeneca plc., Eli Lilly and Company, GlaxoSmithKline plc., Pfizer, Inc., Sanofi S.A. and Merck & Co., Inc.

The report for Global Benzodiazepine Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.

Order Copy of 85 Premium Pages is Available @ https://www.marketresearchfuture.com/order_form.pdf?report_id=2281 .

Regional Analysis:

Depending on geographic region, Benzodiazepine market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Benzodiazepines. Europe is the second-largest market for Benzodiazepines. Asia pacific region is expected to be fastest growing region in Benzodiazepine market due to increasing spending on healthcare infrastructure.

Brief TOC

Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Benzodiazepine Market, by Application
Global Benzodiazepine Market, by Time of Action
Global Benzodiazepine Market, by Regions
Company Landscape
Company Profile
Appendix

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/2281 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.